HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Administration of mAb against alpha E beta 7 prevents and ameliorates immunization-induced colitis in IL-2-/- mice.

Abstract
We previously demonstrated that 2,4,6-trinitrophenol (TNP)-OVA immunization leads to a transmural colitis in the IL-2-/- mouse that is caused by IL-12-driven CD4+ Th1 T cells and resembles human Crohn's disease. The integrin alpha E beta 7 is highly expressed on colonic intraepithelial lymphocytes and has been suggested to function as a homing or retention molecule for intraepithelial lymphocytes. To evaluate the role of alpha E beta 7 in colitis, we administered a mAb against alpha E beta 7 to IL-2-/- mice that were immunized at the same time with TNP-OVA in CFA. To our surprise, this treatment resulted in a significantly reduced colitis severity score, 0-2 vs 3-4, that was associated with a significant reduction in CD4+ lamina propria lymphocyte subpopulation (p < 0.01). In contrast, the total number of splenic CD4+ T cells of treated animals was significantly elevated compared with that of untreated animals (3.2 +/- 0.6 x 107 vs 1.2 +/- 0.2 x 107; p < 0.05). Similarly, functional studies revealed that IFN-gamma production by lamina propria lymphocytes isolated from IL-2-/- TNP-OVA-immunized mice treated with anti-alpha E beta 7 was significantly lower than in untreated IL-2-/- TNP-OVA-immunized mice. In contrast, IFN-gamma production by splenic cells isolated from treated IL-2-/- TNP-OVA-immunized mice was significantly higher than in untreated mice. Finally, TNP-OVA-immunized IL-2-/- mice that were treated after the colitis had been established also showed a significant decrease in mucosal inflammation after alpha E beta 7 mAb administration. Thus, the above findings demonstrate that the onset and maintenance of inflammatory bowel disease depends on the colonic localization of lamina propria CD4+ lymphocytes expressing alpha E beta 7.
AuthorsB R Lúdvíksson, W Strober, R Nishikomori, S K Hasan, R O Ehrhardt
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 162 Issue 8 Pg. 4975-82 (Apr 15 1999) ISSN: 0022-1767 [Print] United States
PMID10202045 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • CD3 Complex
  • Haptens
  • Integrins
  • Interleukin-2
  • Trinitrobenzenes
  • integrin alphaEbeta7
  • trinitrophenyl-ovalbumin
  • Intercellular Adhesion Molecule-1
  • Interferon-gamma
  • Ovalbumin
Topics
  • Animals
  • Antibodies, Monoclonal (administration & dosage, therapeutic use)
  • CD3 Complex (analysis)
  • CD4 Lymphocyte Count
  • Cell Movement (genetics, immunology)
  • Colitis (genetics, immunology, pathology, prevention & control)
  • Female
  • Haptens (immunology)
  • Immunization
  • Injections, Intraperitoneal
  • Integrins (immunology)
  • Intercellular Adhesion Molecule-1 (analysis)
  • Interferon-gamma (biosynthesis)
  • Interleukin-2 (genetics)
  • Intestinal Mucosa (pathology)
  • Lymphocyte Count
  • Lymphocytes (metabolism, pathology)
  • Male
  • Mice
  • Mice, Knockout
  • Ovalbumin (immunology)
  • Spleen (cytology, metabolism)
  • Trinitrobenzenes (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: